Weller, M., Alexander, B., Berry, D., Blondin, N., Buxton, M., Cavenee, W., … Cloughesy, T. (2023). P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In Neuro-Oncology (Vol. 25, pp. ii79–ii80). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noad137.263

Weller, M., B. Alexander, D. Berry, N. Blondin, M. Buxton, W. Cavenee, H. Colman, et al. “P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” In Neuro-Oncology, 25:ii79–80. Oxford University Press (OUP), 2023. https://doi.org/10.1093/neuonc/noad137.263.

Weller M, Alexander B, Berry D, Blondin N, Buxton M, Cavenee W, et al. P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In: Neuro-Oncology. Oxford University Press (OUP); 2023. p. ii79–80.

Weller, M., et al. “P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” Neuro-Oncology, vol. 25, no. Supplement_2, Oxford University Press (OUP), 2023, pp. ii79–80. Crossref, doi:10.1093/neuonc/noad137.263.

Weller M, Alexander B, Berry D, Blondin N, Buxton M, Cavenee W, Colman H, de Groot J, de la Fuente M, Ducray F, Ellingson B, Gordon G, Hyddmark EMV, Khasraw M, Lassman A, Lee E, Lim M, Mellinghoff I, Mikkelsen T, Perry J, Sulman E, Tanner K, Wen P, Wick A, Yung A, Cloughesy T. P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2023. p. ii79–ii80.